Logo image of HUN

HUNTSMAN CORP (HUN) Stock Fundamental Analysis

NYSE:HUN - New York Stock Exchange, Inc. - US4470111075 - Common Stock - Currency: USD

13.235  -0.12 (-0.94%)

Fundamental Rating

3

HUN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 85 industry peers in the Chemicals industry. HUN has a bad profitability rating. Also its financial health evaluation is rather negative. HUN does not seem to be growing, but still is valued expensively. Finally HUN also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year HUN has reported negative net income.
In the past year HUN had a positive cash flow from operations.
HUN had positive earnings in 4 of the past 5 years.
Each year in the past 5 years HUN had a positive operating cash flow.
HUN Yearly Net Income VS EBIT VS OCF VS FCFHUN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

1.2 Ratios

HUN has a Return On Assets of -2.66%. This is in the lower half of the industry: HUN underperforms 72.94% of its industry peers.
HUN has a worse Return On Equity (-6.45%) than 68.24% of its industry peers.
HUN's Return On Invested Capital of 1.04% is on the low side compared to the rest of the industry. HUN is outperformed by 71.76% of its industry peers.
HUN had an Average Return On Invested Capital over the past 3 years of 3.85%. This is below the industry average of 7.05%.
Industry RankSector Rank
ROA -2.66%
ROE -6.45%
ROIC 1.04%
ROA(3y)1.44%
ROA(5y)5.47%
ROE(3y)3.16%
ROE(5y)12.59%
ROIC(3y)3.85%
ROIC(5y)4.46%
HUN Yearly ROA, ROE, ROICHUN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1.3 Margins

The Operating Margin of HUN (1.21%) is worse than 72.94% of its industry peers.
HUN's Operating Margin has declined in the last couple of years.
HUN has a Gross Margin of 14.35%. This is in the lower half of the industry: HUN underperforms 72.94% of its industry peers.
HUN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.21%
PM (TTM) N/A
GM 14.35%
OM growth 3Y-50.02%
OM growth 5Y-28.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.43%
GM growth 5Y-6.74%
HUN Yearly Profit, Operating, Gross MarginsHUN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HUN is destroying value.
HUN has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, HUN has less shares outstanding
The debt/assets ratio for HUN is higher compared to a year ago.
HUN Yearly Shares OutstandingHUN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
HUN Yearly Total Debt VS Total AssetsHUN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

HUN has an Altman-Z score of 1.75. This is a bad value and indicates that HUN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.75, HUN is in line with its industry, outperforming 49.41% of the companies in the same industry.
HUN has a debt to FCF ratio of 23.23. This is a negative value and a sign of low solvency as HUN would need 23.23 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 23.23, HUN is in line with its industry, outperforming 47.06% of the companies in the same industry.
HUN has a Debt/Equity ratio of 0.52. This is a neutral value indicating HUN is somewhat dependend on debt financing.
The Debt to Equity ratio of HUN (0.52) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 23.23
Altman-Z 1.75
ROIC/WACC0.13
WACC7.96%
HUN Yearly LT Debt VS Equity VS FCFHUN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

HUN has a Current Ratio of 1.36. This is a normal value and indicates that HUN is financially healthy and should not expect problems in meeting its short term obligations.
HUN has a worse Current ratio (1.36) than 68.24% of its industry peers.
A Quick Ratio of 0.77 indicates that HUN may have some problems paying its short term obligations.
The Quick ratio of HUN (0.77) is worse than 74.12% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 0.77
HUN Yearly Current Assets VS Current LiabilitesHUN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

3

3. Growth

3.1 Past

HUN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -119.44%.
Looking at the last year, HUN shows a decrease in Revenue. The Revenue has decreased by -1.23% in the last year.
Measured over the past years, HUN shows a decrease in Revenue. The Revenue has been decreasing by -2.35% on average per year.
EPS 1Y (TTM)-119.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.05%
Revenue 1Y (TTM)-1.23%
Revenue growth 3Y-7.68%
Revenue growth 5Y-2.35%
Sales Q2Q%3.49%

3.2 Future

The Earnings Per Share is expected to grow by 184.04% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 4.39% on average over the next years.
EPS Next Y116.23%
EPS Next 2Y230.39%
EPS Next 3Y184.04%
EPS Next 5YN/A
Revenue Next Year3.61%
Revenue Next 2Y4.25%
Revenue Next 3Y4.39%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HUN Yearly Revenue VS EstimatesHUN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B 8B 10B
HUN Yearly EPS VS EstimatesHUN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HUN. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 1164.80, the valuation of HUN can be described as expensive.
68.24% of the companies in the same industry are cheaper than HUN, based on the Price/Forward Earnings ratio.
HUN's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.65.
Industry RankSector Rank
PE N/A
Fwd PE 1164.8
HUN Price Earnings VS Forward Price EarningsHUN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 400 600 800 1K

4.2 Price Multiples

HUN's Enterprise Value to EBITDA ratio is in line with the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as HUN.
Industry RankSector Rank
P/FCF 29.11
EV/EBITDA 10.54
HUN Per share dataHUN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HUN does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as HUN's earnings are expected to grow with 184.04% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y230.39%
EPS Next 3Y184.04%

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 7.67%, HUN is a good candidate for dividend investing.
In the last 3 months the price of HUN has falen by -22.33%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
HUN's Dividend Yield is rather good when compared to the industry average which is at 3.98. HUN pays more dividend than 87.06% of the companies in the same industry.
HUN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.51.
Industry RankSector Rank
Dividend Yield 7.67%

5.2 History

On average, the dividend of HUN grows each year by 9.05%, which is quite nice.
HUN has paid a dividend for at least 10 years, which is a reliable track record.
HUN has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)9.05%
Div Incr Years4
Div Non Decr Years17
HUN Yearly Dividends per shareHUN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

The earnings of HUN are negative and hence is the payout ratio. HUN will probably not be able to sustain this dividend level.
HUN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-92.06%
EPS Next 2Y230.39%
EPS Next 3Y184.04%
HUN Yearly Income VS Free CF VS DividendHUN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

HUNTSMAN CORP

NYSE:HUN (4/25/2025, 10:18:07 AM)

13.235

-0.12 (-0.94%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-17 2025-02-17/amc
Earnings (Next)05-01 2025-05-01/bmo
Inst Owners87.6%
Inst Owner Change0.19%
Ins Owners5.88%
Ins Owner Change3.64%
Market Cap2.30B
Analysts68.57
Price Target20.56 (55.35%)
Short Float %4.1%
Short Ratio1.72
Dividend
Industry RankSector Rank
Dividend Yield 7.67%
Yearly Dividend1.01
Dividend Growth(5Y)9.05%
DP-92.06%
Div Incr Years4
Div Non Decr Years17
Ex-Date03-14 2025-03-14 (0.25)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-73.87%
Min EPS beat(2)-152.09%
Max EPS beat(2)4.35%
EPS beat(4)1
Avg EPS beat(4)-37.43%
Min EPS beat(4)-152.09%
Max EPS beat(4)4.35%
EPS beat(8)2
Avg EPS beat(8)-24.63%
EPS beat(12)4
Avg EPS beat(12)-19.7%
EPS beat(16)8
Avg EPS beat(16)-12.62%
Revenue beat(2)0
Avg Revenue beat(2)-1.04%
Min Revenue beat(2)-1.66%
Max Revenue beat(2)-0.41%
Revenue beat(4)0
Avg Revenue beat(4)-1.6%
Min Revenue beat(4)-3.32%
Max Revenue beat(4)-0.41%
Revenue beat(8)1
Avg Revenue beat(8)-2.25%
Revenue beat(12)2
Avg Revenue beat(12)-2.22%
Revenue beat(16)4
Avg Revenue beat(16)-2.39%
PT rev (1m)-2.24%
PT rev (3m)-13.71%
EPS NQ rev (1m)-38%
EPS NQ rev (3m)-240.01%
EPS NY rev (1m)-96.89%
EPS NY rev (3m)-98.61%
Revenue NQ rev (1m)-1.31%
Revenue NQ rev (3m)-4.74%
Revenue NY rev (1m)-0.69%
Revenue NY rev (3m)-1.45%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1164.8
P/S 0.38
P/FCF 29.11
P/OCF 8.74
P/B 0.78
P/tB 1.18
EV/EBITDA 10.54
EPS(TTM)-0.07
EYN/A
EPS(NY)0.01
Fwd EY0.09%
FCF(TTM)0.45
FCFY3.44%
OCF(TTM)1.51
OCFY11.44%
SpS34.74
BVpS16.87
TBVpS11.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.66%
ROE -6.45%
ROCE 1.32%
ROIC 1.04%
ROICexc 1.11%
ROICexgc 1.36%
OM 1.21%
PM (TTM) N/A
GM 14.35%
FCFM 1.31%
ROA(3y)1.44%
ROA(5y)5.47%
ROE(3y)3.16%
ROE(5y)12.59%
ROIC(3y)3.85%
ROIC(5y)4.46%
ROICexc(3y)4.26%
ROICexc(5y)5.51%
ROICexgc(3y)5.21%
ROICexgc(5y)6.86%
ROCE(3y)4.87%
ROCE(5y)5.65%
ROICexcg growth 3Y-54.19%
ROICexcg growth 5Y-26.52%
ROICexc growth 3Y-53.71%
ROICexc growth 5Y-28.3%
OM growth 3Y-50.02%
OM growth 5Y-28.11%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.43%
GM growth 5Y-6.74%
F-Score5
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 23.23
Debt/EBITDA 4.17
Cap/Depr 63.67%
Cap/Sales 3.05%
Interest Coverage 0.95
Cash Conversion 72.65%
Profit Quality N/A
Current Ratio 1.36
Quick Ratio 0.77
Altman-Z 1.75
F-Score5
WACC7.96%
ROIC/WACC0.13
Cap/Depr(3y)81.07%
Cap/Depr(5y)89.35%
Cap/Sales(3y)3.4%
Cap/Sales(5y)3.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-119.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.05%
EPS Next Y116.23%
EPS Next 2Y230.39%
EPS Next 3Y184.04%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.23%
Revenue growth 3Y-7.68%
Revenue growth 5Y-2.35%
Sales Q2Q%3.49%
Revenue Next Year3.61%
Revenue Next 2Y4.25%
Revenue Next 3Y4.39%
Revenue Next 5YN/A
EBIT growth 1Y-28.43%
EBIT growth 3Y-53.86%
EBIT growth 5Y-29.79%
EBIT Next Year247.32%
EBIT Next 3Y74.29%
EBIT Next 5YN/A
FCF growth 1Y476.19%
FCF growth 3Y-49.41%
FCF growth 5Y-33.84%
OCF growth 1Y25.84%
OCF growth 3Y-34.87%
OCF growth 5Y-21.76%